Fractional business development is well established in the US and UK. In Australia, it has been slower to take hold, but the conditions that drove its growth elsewhere are now present here: health technology ventures, digital health startups and early-stage medtech companies rarely have the revenue to justify a full-time senior BD hire, yet the commercial work still needs to be done. Founders who cannot justify a full-time BD hire are seeking senior-level capability on a part-time basis. Getting that engagement right is harder than it looks, and the mistakes tend to follow a pattern.
The main risk is not hiring the wrong person. It is hiring the right person, only to make them ineffective.
What health BD requires
General business development experience does not transfer cleanly to health. The Australian health system has its own commissioning logic, relationships, regulatory constraints and timelines. A medtech company entering Australia needs someone who understands how the TGA pathway intersects with procurement, how hospitals purchase, and which clinical champions carry weight and why. A health technology venture seeking to work within the primary care system needs someone who understands how commissioning decisions get made, what evidence thresholds apply, and which relationships carry weight, none of which is visible from the outside.
These things accumulate over years of working inside the system, making mistakes, watching how decisions get made from the inside, and building the kind of relationships that only exist because you were present when something difficult happened and handled it well. They do not transfer from a different sector and they do not arrive with a 'fast learner'.
A junior operator can execute a task list. They cannot read a room, reframe a pitch on the spot when the funder's priorities have shifted since the last meeting, or tell a founder plainly that their product is not ready for the conversation they want to have. That last capability is the one that founders underestimate most, and the one that costs them most when it is absent.
Research published in the American Economic Review by Azoulay, Jones, Kim and Miranda (2020), drawing on 2.7 million US business founders, found that prior industry experience predicts much higher rates of entrepreneurial success. Founders with at least three years of experience in the same industry as their startup were twice as likely to build a top 0.1% growth company.
The same study found no evidence that founders in their twenties are especially likely to succeed. The most successful founders were, on average, 45 years old when they started their highest-growth ventures.
Health tech compounds this further. Insufficient market knowledge and the inability to navigate regulatory and procurement complexities without deep prior exposure to the system repeatedly appear in failure post-mortems for digital health startups, which fail at a rate of around 98% within two years.
The founder psychology problem
The pattern that derails more health BD engagements than any skills gap is founder psychology: founders who hire senior capability and then structurally prevent it from working.
The founder who will not follow basic market setup discipline, skipping the groundwork because they are convinced their product speaks for itself, and losing the window entirely when a better-prepared competitor moves first.
The founder who treats every strategic recommendation as a negotiation rather than a decision, and who genuinely believes their own view is the correct one, makes it impossible to execute anything cleanly. The founder who wants the credibility of having an experienced operator in the room but cannot tolerate the honest assessments that come with the territory.
This is not a personality critique. It is a structural problem that clinical psychologist Martin Dubin, writing in Psychology Today Australia (December 2025), describes plainly: founder failure is rarely an issue of intelligence, talent, or work ethic. More often, it is a misalignment between how founders see themselves and what their role now requires. When the identity that fuelled early success becomes what holds the company back, founders resist the shift because staying with what they know feels unquestionably correct, even as the company stalls.
In health specifically, this plays out in a particular way. Many health founders are clinicians or technically trained innovators who have solved a genuine clinical problem. That problem-solving identity is real and valuable, but it does not extend automatically to commercial execution. The market does not care how good the product is if the founder cannot hear that the go-to-market approach needs to change.
Data from Startup Daily (2025) shows that 75% of Australian founders felt overwhelmed in the past six months, and 39% rated their own mental health as poor or fair. Under that kind of pressure, decision-making suffers and the people hired to help are often the first to feel it.
The clients who get results are almost always those who can hear that an approach is not working without treating it as a personal attack, who understand that the operator's job is to tell the truth about the market rather than confirm what the founder already believes. That kind of self-awareness is rarer than it sounds in a founder population that has typically succeeded by being certain.
The age and experience gap the market ignores
The popular narrative around startups skews young: Zuckerberg at 19, Gates at 20, Jobs at 21. These cases are exceptional, and the research is detailed enough that they are not representative.
The Azoulay et al. (2020) study found that a 50-year-old founder has 1.8 times greater odds of starting a successful company than a 30-year-old, and that 20-year-old founders have the lowest success rates of all. Jones and his co-authors conclude that the likelihood of entrepreneurial success rises consistently with age, and that prior industry experience is the strongest individual predictor of high-growth outcomes.
The venture capital market does not reflect this. VC investors disproportionately fund younger founders despite the data showing lower success rates. The same research notes this as a likely misallocation: venture capital does not appear to be allocated to the firms with the highest growth potential, even though it consistently favours youth over experience.
For health ventures specifically, the implication is direct. If your BD hire or fractional partner is early in their career, lacks sector relationships and has never navigated the specific procurement, regulatory or commissioning environment you are operating in, they cannot compensate for that with enthusiasm or general commercial capability. Health is not a sector where you can learn the system while you are supposed to be selling into it.
The research is not ambiguous, and the health sector failure rates suggest the mythology is costing founders real money and real time.
What AI has changed
The economics of fractional BD have shifted in the past two years in ways that favour experienced operators specifically.
I work with AI agents that function as dedicated employees: one handles research and list development, another manages routine CRM tasks, and another runs outreach sequencing and follow-up. Work that previously required a separate hire or hours of manual effort runs in the background while I focus on the work that requires judgement, relationships and sector knowledge. The tools I use day to day, Claude Cowork for writing and analysis, Perplexity for research, Kimi for additional fact validation, Cowork for agent management and GitHub Copilot for product development, are not experiments. They are how the work gets done.
The result is that one experienced operator now delivers what used to require a small team: pipeline management, content production, stakeholder research, CRM setup, outreach sequencing, automated marketing, proposal development and reporting, running in parallel without the coordination overhead, the ramp-up time or the cost of multiple hires. Founders who previously had to choose between a full-time BD hire they could not justify and a junior contractor who needed managing now have a third option that did not exist five years ago.
The experience gap has not closed. In health, it has widened as the system grows more complex. What AI has done is remove the productivity argument for hiring younger, cheaper workers, which was always the weaker argument anyway.
What the Australian market is starting to figure out
Australian healthcare has been slower than comparable markets to adopt the fractional model, partly because professional networks here are tight enough that word of mouth has always been the dominant sourcing mechanism. You hired who you knew, or who someone you trusted knew. That still happens and still produces good outcomes when the referral is sound.
The range of organisations needing this kind of support has expanded beyond those traditional networks. Digital health ventures, condition-specific NFPs, new entrants from adjacent sectors, and international companies entering the Australian market: these organisations often do not have the relationships to source through traditional channels, and they are finding their way to the fractional model through research rather than referral.